Literature DB >> 10204123

Clostridium difficile: an update on its epidemiology and role in hospital outbreaks in England and Wales.

T Djuretic1, P G Wall, J S Brazier.   

Abstract

Data from the surveillance system of general outbreaks of infectious intestinal disease and from laboratory reports collated by the Communicable Disease Surveillance Centre (CDSC) and requests for outbreak investigation by the PHLS Anaerobe Reference Unit were used to evaluate the current epidemiology of Clostridium difficile infection in England and Wales. Between January 1992 and December 1996, CDSC received 10,220 laboratory reports of C difficile isolation from patient's faeces and 26,873 of toxin in faeces. Over 75% of all reports were of people aged 64 years and over. The surveillance system captured a minimum data set on 694 hospital outbreaks of infectious intestinal disease. C. difficile was responsible for 109 (15%) outbreaks affecting 1625 people, of whom 1152 were found to have a C. difficile toxin producing strain. The median duration of outbreaks was 11 days. Fingerprinting by Pyrolysis Mass Spectrometry (PMS) was performed by the PHLS Anaerobe Reference Unit in 60 outbreaks, and typing by Polymerase Chain Reaction ribotyping (PCR) in 14.

Entities:  

Mesh:

Year:  1999        PMID: 10204123     DOI: 10.1016/s0195-6701(99)90018-x

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

2.  Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1).

Authors:  Warren N Fawley; Peter Parnell; Paul Verity; Jane Freeman; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 3.  Update on Clostridium difficile infection.

Authors:  C S Alcantara; R L Guerrant
Journal:  Curr Gastroenterol Rep       Date:  2000-08

4.  Effects of inoculum, pH, and cations on the in vitro activity of fidaxomicin (OPT-80, PAR-101) against Clostridium difficile.

Authors:  F Babakhani; J Seddon; N Robert; Y-K Shue; P Sears
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

5.  Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans.

Authors:  Anna M Buchner; Amnon Sonnenberg
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

6.  Epidemiology of Clostridioides difficile infections, France, 2010 to 2017.

Authors:  Mélanie Colomb-Cotinat; Laetitia Assouvie; Julien Durand; Côme Daniau; Lucie Leon; Sylvie Maugat; Sophan Soing-Altrach; Cécile Gateau; Jeanne Couturier; Isabelle Arnaud; Pascal Astagneau; Anne Berger-Carbonne; Frédéric Barbut
Journal:  Euro Surveill       Date:  2019-08

7.  Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital.

Authors:  Prameet M Sheth; Katya Douchant; Yvonne Uyanwune; Michael Larocque; Arravinth Anantharajah; Emily Borgundvaag; Lorraine Dales; Liz McCreight; Laura McNaught; Christine Moore; Kelsey Ragan; Allison McGeer; George Broukhanski
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.